Cargando…

Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports

BACKGROUND: Permanent neonatal diabetes mellitus (PNDM) presents with dehydration and hyperglycemia, which usually occurs during the first 12 months of life. Activating mutations of beta-cell adenosine triphosphate-sensitive potassium [KATP] channel subunits that cause opening of the channel are ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Razzaghy-Azar, Maryam, Nourbakhsh, Mitra, Talea, Ali, Mohammad Amoli, Mahsa, Nourbakhsh, Mona, Larijani, Bagher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543822/ https://www.ncbi.nlm.nih.gov/pubmed/34696808 http://dx.doi.org/10.1186/s13256-021-03052-5

Ejemplares similares

Effects of extremely low frequency electromagnetic fields on paraoxonase serum activity and lipid peroxidation metabolites in rat
por: Seifirad, Soroush, et al.
Publicado: (2014)

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013)

An Evaluation of Acylated Ghrelin and Obestatin Levels in Childhood Obesity and Their Association with Insulin Resistance, Metabolic Syndrome, and Oxidative Stress
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2016)

Comparison of Insulin Glargine and Detemir Effects on Hormones of Appetite and Metabolic Control in Patients with Type 1 Diabetes: A Randomized Clinical Trial
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2021)

Angiopoietin-Like Proteins 2 and 3 in Children and Adolescents with Obesity and Their Relationship with Hypertension and Metabolic Syndrome
por: Arab Sadeghabadi, Zahra, et al.
Publicado: (2021)

Sestrin2 and Beclin1 levels in Polycystic Ovary Syndrome
por: Saeedi, Vahid, et al.
Publicado: (2021)

Assessment of global histone acetylation in pediatric and adolescent obesity: Correlations with SIRT1 expression and metabolic-inflammatory profiles
por: Taghizadeh, Nima, et al.
Publicado: (2023)

The effect of trans-palmitoleic acid on cell viability and sirtuin 1 gene expression in hepatocytes and the activity of peroxisome-proliferator-activated receptor-alpha
por: Farokh Nezhad, Ramesh, et al.
Publicado: (2020)

Identification of a novel nonsense mutation and a missense substitution in the AGPAT2 gene causing congenital generalized lipodystrophy type 1
por: Haghighi, Amirreza, et al.
Publicado: (2012)

Permanent neonatal diabetes mellitus
por: Al-Matary, Abdulrahman, et al.
Publicado: (2012)

Association of microRNA gene polymorphisms with Type 2 diabetes mellitus: A systematic review and meta-analysis
por: Gholami, Morteza, et al.
Publicado: (2020)

Repaglinide-Induced Acute Pancreatitis
por: Udongwo, Ndausung, et al.
Publicado: (2021)

Meglitinides increase the risk of hypoglycemia in diabetic patients with advanced chronic kidney disease: a nationwide, population-based study
por: Wu, Pei-Chen, et al.
Publicado: (2017)

Two Polymorphisms in the Epithelial Cell-Derived Neutrophil-Activating Peptide (ENA-78) Gene
por: Amoli, Mahsa M., et al.
Publicado: (2005)

Permanent neonatal diabetes mellitus in China
por: Huang, Ke, et al.
Publicado: (2014)

Permanent neonatal diabetes mellitus in China
por: Huang, Ke, et al.
Publicado: (2015)

Recurrent Hepatitis in Two Iranian Children: A Novel (Q166R) Mutation in EIF2AK3 Leading to Wolcott-Rallison Syndrome
por: Behnam, Babak, et al.
Publicado: (2013)

An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity
por: Gholami, Morteza, et al.
Publicado: (2020)

Formulation and Evaluation of Transdermal Patch of Repaglinide
por: Prajapati, Shailesh T., et al.
Publicado: (2011)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus
por: Younas, Amna, et al.
Publicado: (2021)

Polymorphisms of Antioxidant Genes as a Target for Diabetes Management
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2017)

Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
por: Ma, J., et al.
Publicado: (2014)

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012)

Replication of TCF7L2 rs7903146 association with type 2 diabetes in an Iranian population
por: Amoli, Mahsa M., et al.
Publicado: (2010)

Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea
por: Omori, Kazuno, et al.
Publicado: (2018)

Efficacy and safety of Samtropin™ recombinant human growth hormone; a double-blind randomized clinical trial
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2014)

Investigating Genetic Mutations in a Large Cohort of Iranian Patients with Congenital Hyperinsulinism
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2022)

Development of Spectrofluorimetric and HPLC Methods for In vitro Analysis of Repaglinide
por: Kaushal, N., et al.
Publicado: (2010)

TNF-α and IFN-γ gene variation and genetic susceptibility to type 1 diabetes and its microangiopathic complications
por: Bazzaz, Javad Tavakkoly, et al.
Publicado: (2014)

TGF-β1 and IGF-I gene variations in type 1 diabetes microangiopathic complications
por: Bazzaz, Javad Tavakkoly, et al.
Publicado: (2014)

Iranian neonatal diabetes mellitus due to mutation in PDX1 gene: a case report
por: Sahebi, Leyla, et al.
Publicado: (2019)

Gender Identity in Patients with Congenital Adrenal Hyperplasia
por: Razzaghy-Azar, Maryam, et al.
Publicado: (2017)

Effect of combination therapy with repaglinide and metformin hydrochloride on glycemic control in Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2014)

Comparison of Glycemic Excursion in Patients with New Onset Type 2 Diabetes Mellitus before and after Treatment with Repaglinide
por: Hezarkhani, Sharabeh, et al.
Publicado: (2013)

Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus
por: Wang, Liang-Chen, et al.
Publicado: (2018)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Moses, Robert
Publicado: (2009)

Clinical Effects of Exercise Rehabilitation Combined with Repaglinide in the Treatment of Diabetes
por: Li, Yan, et al.
Publicado: (2022)

A Variation in the ABCC8 Gene Is Associated with Type 2 Diabetes Mellitus and Repaglinide Efficacy in Chinese Type 2 Diabetes Mellitus Patients
por: Zhou, Xueyan, et al.
Publicado: (2019)

SLC34A3 Intronic Deletion in a New Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2012)

Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and type 2 diabetes
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_spun8481o7ggvj17pain6t5ivm